IVIG - Is it the answer? Maternal administration of immunoglobulin for severe fetal red blood cell alloimmunisation during pregnancy: A case series

Australian and New Zealand Journal of Obstetrics and Gynaecology

Volumn 49, Issue 6, 2009, Pages 612-618

  Connan, Kirsten ^a   Kornman, Louise ^a   Savoia, Helen ^a   Palma Dias, Ricardo ^a   Rowlands, Shelley ^a  

^a ROYAL WOMEN'S HOSPITAL   (Australia)

Author keywords

Alloimmunisation; Erythroblastosis; Immunoglobulins; Intravenous; Pregnancy complications

Indexed keywords

IMMUNOGLOBULIN; IMMUNOGLOBULIN G; INTRAGAM P; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; DISEASE SEVERITY; DRUG INDICATION; FEMALE; FETAL RED BLOOD CELL ALLOIMMUNIZATION; FETUS; FETUS DISEASE; HIGH RISK PATIENT; HUMAN; MACULOPAPULAR RASH; NEWBORN MORBIDITY; PREGNANCY; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; ANEMIA, HEMOLYTIC, AUTOIMMUNE; BLOOD TRANSFUSION, INTRAUTERINE; COHORT STUDIES; DRUG ADMINISTRATION SCHEDULE; ERYTHROBLASTOSIS, FETAL; FEMALE; HOSPITALS, MATERNITY; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; PREGNANCY; RETROSPECTIVE STUDIES; RH ISOIMMUNIZATION; TREATMENT OUTCOME;

EID: 73449128030     PISSN: 00048666     EISSN: 1479828X     Source Type: Journal    
DOI: 10.1111/j.1479-828X.2009.01091.x     Document Type: Article

References (33)

1. Van Kamp IL., Klumper FJ, Meerman RH, Oepkes D, Scherjon SA, Kanhani HH. Treatment of fetal anemia due to red-cell alloimmunisation with intrauterine transfusions in the Netherlands, 1988-1999. Acta Obstet Gynecol Scand 2004 83 : 731 737.
2. Van Kamp IL, Klumper FJ, Oepkes D et al. Complications of intrauterine intravascular transfusion for fetal anemia due to maternal red-cell alloimmunization. Am J Obstet Gynecol 2005 (Jan 192 : 171 177.
3. Ghidini A, Sepulveda W, Lockwood CJ, Romero R. Complications of fetal blood sampling. Am J Obstet Gynecol 1993 168 : 1339 1344.
4. Radunovic N, Lockwood CJ, Alvarez M, Plecas D, Chitkara U, Berkowitz RL. The severly anemic and hydropic isoimmune fetus: changes in fetal hematocrit associated with intrauterine death. Obstet Gynaecol 1992 79 : 390 393.
5. Ruma MS, Moise KJ Jr., Kim E et al. Combined plasmapheresis and intravenous immune globulin for the treatment of severe maternal red cell alloimmunisation. Am J Obstet Gynecol 2007 (Feb 196 (2 e1 e6.
6. Odendaal HJ, King JB, Oosthuizen OJ. Severe rhesus iso-immunisation successfully treated with apheresis and azathioprine. S Afr Med J 1986 (Jan 18 69 (2 122 124.
7. Palfi M, Hildén JO, Matthiesen L, Selbing A, Berlin G. A case of severe Rh (D) alloimmunisation treated by intensive plasma exchange and high-dose intravenous immunoglobulin. Transfus Apher Sci 2006 35 (2 131 136.
8. Newland AC. The use and mechanisms of action of IVIG; an update. Br J Haematol 1989 72 : 301 305.
9. Todd AA, Yap PL. Application of intravenous immunoglobulin in haematology. Blood Rev 1992 (Jun 6 (2 105 117.
10. Clark AL. Clinical uses of intravenous immunoglobulin in pregnancy. Clin Obstet Gynecol 1999 (Jun 42 (2 368 380.
11. Giers G, Hoch J, Bauer H et al. Therapy with intravenous immunoglobulin G (ivIgG) during pregnancy for fetal alloimmune (HPA-1a(Zwa)) thrombocytopaenia purpura. Prenat Diagn 1996 (Jun 16 (6 495 502.
12. Gottvall T, Selbing A. Alloimmunisation during pregnancy treated with high dose intravenous immunoglobulin. Effects on fetal hemoglobin concentration and anti-D concentrations in the mother and fetus. Acta Obstet Gynecol Scand 1995 74 : 777 783.
13. Morgenstern GR, Measday B, Hedge UM. Autoimmune thrombocytopaenia in pregnancy: a new approach to management. BMJ 1983 287 : 584 585.
14. Barton JC, Saleh MN, Stedman CM, Lobuglio AF. Case report. Immune thrombocytopaenia. Effects of maternal gamma globulin infusion on maternal and fetal serum, platelet and monocyte IgG. Am J Med Sci 1987 293 : 112 118.
15. Kaplan C, Daffos F, Forestier F et al. Management of alloimmune thrombocytopenia: antenatal diagnosis and in utero transfusion of maternal platelets. Blood 1988 72 : 340 343.
16. Berlin G, Selbing A, Ryden G. Rh hemolytic disease treated with high dose IVIG. Lancet 1985 1 : 1153.
17. Scott JR, Branch DW, Kochenour NK, Ward K. Intravenous immunoglobulin treatment of pregnant patients with recurrent pregnancy loss caused by antiphospholipid antibodies and Rh immunization. Am J Obstet Gynecol 1988 159 : 1055 1056.
18. De La Camara C, Arrieta R, Gonalez A, Iglesias E, Omenaca F. High-dose intravenous immunoglobulin as the sole prenatal treatment for severe Rh immunisation. N Engl J Med 1988 (Feb 25 318 (8 519 520.
19. Chitkara U, Bussel J, Alvarez M, Lynch L, Meisel RL, Berkowitz RL. High-dose intravenous gammaglobulin: Does it have a role in the treatment of severe erythroblastosis fetalis? Obstet Gynecol 1990 (Oct); 76 (4 703 708.
20. Margulies M, Voto LS, Mathet E, Margulies M. High-dose intravenous IgG for the treatment of severe rhesus alloimmunisation. Vox Sang 1991 61 (3 181 189.
21. Deka D, Buckshee K, Kinra G. Intravenous immunoglobulin as primary therapy or adjuvant therapy to intrauterine fetal blood transfusion: a new approach in the management of severe Rh-immunisation. J Obstet Gynaecol Res 1996 (Dec 22 (6 561 567.
22. Voto LS, Mathet ER, Zapaterio JL, Orti J, Lede RL, Margulies M. High-dose gammaglobulin (IVIG) followed by intrauterine transfusions (IUTs): a new alternative for the treatment of severe fetal haemolytic disease. J Perinat Med 1997 25 (1 85 88.
23. Dooren MC, van Kamp IL, Scherpenisse JW et al. No beneficial effect of low-dose fetal intravenous gammaglobulin administration in combination with intravascular transfusion in severe RhD haemolytic disease. Vox Sang 1994 66 (4 253 257.
24. Alonso JG, Decaro J, Marrero A, Lavelle E, Martell M, Cuadro JC. Repeated direct fetal intravascular high-dose immunoglobulin therapy for the treatment of Rh haemolytic disease. J Perinat Med 1994 22 (5 415 419.
25. Kriplani A, Malhotra Singh B, Mandal K. Fetal intravenous immunoglobulin therapy in rhesus hemolytic disease. Gynecol Obstet Invest 2007 63 (3 176 180. Epub2006 Dec 1.
26. Maciulevicience R, Gaurilcikas A, Simaaviciute D et al. Fetal middle cerebral artery Doppler velocimetry in cases of rhesus alloimmunisation. J Matern Fetal Neonatal Med 2008 (Jun 21 (6 361 365.
27. Mari G, Deter RL, Carpenter RL et al. Noninvasive diagnosis by Doppler ultrasonography of fetal anemia due to maternal red-cell alloimmunization. Collaborative Group for Doppler Assessment of the Blood Velocity in Anemic Fetuses. N Engl J Med 2000 (Jan 6 342 (1 9 14.
28. Zimmerman R, Carpenter RJ, Durig P, Mari G. Longitudinal measurement of peak systolic velocity in the fetal middle cerebral artery for monitoring pregnancies complicated by red cell alloimmunisation: a prospective multicentre trial with intention-to-treat. BJOG 2002 109 (7 746 752.
29. Fox C, Martin W, Somerset DA, Thompson PJ, Kilby MD. Early intraperitoneal transfusion and adjuvant maternal immunoglobulin therapy in the treatment of severe red cell alloimmunisation prior to fetal intravascular transfusion. Fetal Diagn Ther 2008 23 : 159 163.
30. Grant SR, Kilby MD, Meer L, Weaver JB, Gabra GS, Whittle MJ. The outcome of pregnancy in Kell alloimmunisation. BJOG 2000 (Apr 107 (4 481 485.
31. McKenna DS, Nagaraja HN, O'Shaughnessy R. Management of pregnancies complicated by anti-Kell isoimmunisation. Obstet Gynecol 1999 (May 93 : 667 673.
32. Duhem C, Dicato MA, Ries F. Side-effects of intravenous immune globulin. Clin Exp Immunol 1994 97 : 79 83.
33. Porter TF, Silver RM, Jackson GM, Branch DW, Scott JR. Intravenous immune globulin in the management of severe Rh D hemolytic disease. Obstet Gynecol Surv 1997 52 (3 193 197.